US 11,813,287B1
الصحة - Health
2023
مكتب البراءات الأمريكي - US Patent Office
Hany MohamedAbdEl-Lateef Ahmed, Al-Ahsa(SA); Saadeldin Elsayed IbrahimShabaan, Al-Ahsa (SA); Jihad WadaiSalehAlessa, Al-Ahsa (SA)
Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe3O4 microparticles, at least one organoselenium compound, at least one essential oil, and incense. The Covid-19 binding aerosols may be formulated for use in any product that is capable of emitting aerosols, including but not limited to air fresheners, incense, or the like. The Fe3O4 microparticles may have an average size of 5,000 nm - 10,000 nm (between 5-10 μm). The Covid-19 binding aerosols are formulated as aerosol compositions having an average size of greater than 60 μm - 100 μm to ensure effective binding to virions.